Auswahl der wissenschaftlichen Literatur zum Thema „Immunosuppressive agents Mechanism of action“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Immunosuppressive agents Mechanism of action" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Immunosuppressive agents Mechanism of action":
McDevitt, Lisa M. „Immunosuppressive Agents on the Horizon“. Journal of Pharmacy Practice 16, Nr. 6 (Dezember 2003): 434–41. http://dx.doi.org/10.1177/0897190003259384.
Grbovic, Leposava, und Miroslav Radenkovic. „Therapeutic use of glucocorticoids and immunosuppressive agents“. Srpski arhiv za celokupno lekarstvo 133, Suppl. 1 (2005): 67–73. http://dx.doi.org/10.2298/sarh05s1067g.
Robak, Tadeusz, Ewa Lech-Maranda, Anna Korycka und Ewa Robak. „Purine Nucleoside Analogs as Immunosuppressive and Antineoplastic Agents: Mechanism of Action and Clinical Activity“. Current Medicinal Chemistry 13, Nr. 26 (01.11.2006): 3165–89. http://dx.doi.org/10.2174/092986706778742918.
Valdoleiros, Sofia R., Isabel Furtado, Carolina Silva, Inês Correia Gonçalves, André Santos Silva, Olga Vasconcelos, Ana Aboim Horta et al. „Protocolo de Prevenção e Tratamento de Infeções Associadas à Terapêutica Imunossupressora de Doenças Autoimunes“. Acta Médica Portuguesa 34, Nr. 6 (01.06.2021): 469. http://dx.doi.org/10.20344/amp.15625.
Bauer, Andrea C., Rodrigo F. Franco und Roberto C. Manfro. „Immunosuppression in Kidney Transplantation: State of the Art and Current Protocols“. Current Pharmaceutical Design 26, Nr. 28 (31.08.2020): 3440–50. http://dx.doi.org/10.2174/1381612826666200521142448.
Gorantla, Vijay S., John H. Barker, Jon W. Jones, Kaustubha Prabhune, Claudio Maldonado und Darla K. Granger. „Immunosuppressive agents in transplantation: Mechanisms of action and current anti-rejection strategies“. Microsurgery 20, Nr. 8 (2000): 420–29. http://dx.doi.org/10.1002/1098-2752(2000)20:8<420::aid-micr13>3.0.co;2-o.
Taylor, Anna L., Christopher J. E. Watson und J. Andrew Bradley. „Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy“. Critical Reviews in Oncology/Hematology 56, Nr. 1 (Oktober 2005): 23–46. http://dx.doi.org/10.1016/j.critrevonc.2005.03.012.
Stepkowski, Stanislaw M. „Molecular targets for existing and novel immunosuppressive drugs“. Expert Reviews in Molecular Medicine 2, Nr. 4 (21.06.2000): 1–23. http://dx.doi.org/10.1017/s1462399400001769.
Tan, Marcus, Thurston Heng und Anselm Mak. „The Potential Use of Metformin, Dipyridamole, N-Acetylcysteine and Statins as Adjunctive Therapy for Systemic Lupus Erythematosus“. Cells 8, Nr. 4 (06.04.2019): 323. http://dx.doi.org/10.3390/cells8040323.
Nelson, R. D., N. Shibata, R. P. Podzorski und M. J. Herron. „Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action.“ Clinical Microbiology Reviews 4, Nr. 1 (Januar 1991): 1–19. http://dx.doi.org/10.1128/cmr.4.1.1.
Dissertationen zum Thema "Immunosuppressive agents Mechanism of action":
Gudgeon, M. C. „Studies on the mechanism of action of cyclosporin A“. Thesis, University of Sussex, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.378279.
Jones, Terence Edward. „Economically beneficial drug interactions with cyclosporin and tacroliumus : clinical studies in recipients of kidney and liver transplants“. Title page, contents and abstract only, 2000. http://web4.library.adelaide.edu.au/theses/09PH/09phj79.pdf.
Lui, Sing-leung, und 雷聲亮. „The in vivo mechanism of actions of mycophenolate mofetil: insights from murine models of allograft rejection,endotoxemia, ischemia reperfusion injury and lupus nephritis“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2003. http://hub.hku.hk/bib/B26625374.
Christie, Andrew W. „Mechanism of action of selected anti-lipolytic agents in adipocytes“. Thesis, University of Newcastle Upon Tyne, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.282761.
Meister, Gabriel T. „Antiviral mechanism(s) of the experimental immunosuppressive agent leflunomide against human cytomegalovirus and polyomavirus“. Connect to this title online, 2005. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1111428519.
Title from first page of PDF file. Document formatted into pages; contains xiii, 127 p.; also includes graphics (some col.) Includes bibliographical references (p. 113-127). Available online via OhioLINK's ETD Center
Guo, Hong, und 郭紅. „Effects of anti-DNA antibodies on pleural mesothelial cells: in vitro studies to explore thepathogenetic mechanism of pulmonary lupus“. Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2003. http://hub.hku.hk/bib/B26631945.
published_or_final_version
abstract
toc
Medicine
Master
Master of Philosophy
Hearn, Jessica M. „Integrating cell screening and mechanism of action data for organometallic anticancer agents“. Thesis, University of Warwick, 2015. http://wrap.warwick.ac.uk/68071/.
HAMED, SAJA H. „EFFICACY AND MECHANISM OF ACTION OF A NEW TYROSINASE INHIBITORY AGENT“. University of Cincinnati / OhioLINK, 2004. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1085566152.
Lohmeyer, Matthias. „The mechanism of action of antitumour lipid agents related to platelet-activating factor (PAF)“. Thesis, University of Cambridge, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.319528.
Xia, Yixuan. „Anticancer efficacy and mechanism of action studies of the potent plant cycloheptapeptide compounds mavacyocines“. HKBU Institutional Repository, 2020. https://repository.hkbu.edu.hk/etd_oa/817.
Bücher zum Thema "Immunosuppressive agents Mechanism of action":
Bach, Jean-François. The mode of action of immunosuppressive agents. 2. Aufl. Amsterdam: Elsevier Science Publishers, 1985.
Bach, J. F. The mode of action of immunosuppressive agents. 2. Aufl. Amsterdam: Elsevier, 1985.
Nihon Junkanki Gakkai. Gakujutsu Shūkai. Current topics in antiarrhythmic agents: Mode of action and clinical usage : International Satellite Symposium of the 53rd Annual Meeting of the Japanese Circulation Society, Nagoya, Japan, March 27-28, 1989. Herausgegeben von Toyama Junji 1937- und Hondeghem Luc. Amsterdam: Excerpta Medica, 1989.
Workshop, on Neurotransmitters and Diseases (6th 1989 Kōbe-shi Japan). Regulatory roles of neuropeptides: Proceedings of the Sixth Workshop on Neurotransmitters and Diseases, Kobe, June 17, 1989. Amsterdam, The Netherlands: Excerpta Medica, 1989.
International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy (7th 1995 Amsterdam, Netherlands). Platinum and other metal coordination compounds in cancer chemotherapy 2. New York: Plenum Press, 1996.
International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy (6th 1991 San Diego, Calif.). Platinum and other metal coordination compounds in cancer chemotherapy. New York: Plenum Press, 1991.
OHOLO Conference (34th 1989 Elat, Israel). Calcium channel modulators in heart and smooth muscle: Basic mechanisms and pharmacological aspects : proceedings of the 33rd [i.e. 34th] Oholo Conference, Eilat, Israel, 1989. Rehovot, Israel: Balaban Publishers, 1990.
Cooper, K. E. Fever and antipyresis: The role of the nervous system. Cambridge: Cambridge University Press, 1995.
Misbah, Siraj. Immunosuppressive therapy and therapeutic monoclonal antibodies. Herausgegeben von Patrick Davey und David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0302.
McCulloh, Russell J., und Steven M. Opal. Drug-induced depression of immunity in the critically ill. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0290.
Buchteile zum Thema "Immunosuppressive agents Mechanism of action":
Biollaz, J., A. Munafo und T. Buclin. „Mechanism of Action of Vasodilating Agents“. In Update in Intensive Care and Emergency Medicine, 275–88. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-83453-0_19.
Rao, S. Ramachandra. „Mechanism of the Action of Modifying Agents“. In Surface Chemistry of Froth Flotation, 575–619. Boston, MA: Springer US, 2004. http://dx.doi.org/10.1007/978-1-4419-9124-9_12.
Rao, S. Ramachandra. „Mechanism of the Action of Modifying Agents“. In Surface Chemistry of Froth Flotation, 575–619. Boston, MA: Springer US, 2004. http://dx.doi.org/10.1007/978-1-4757-4302-9_12.
Kitz, R. J. „Anticholinesterase Agents: Their Mechanism of Action and Use“. In Anesthesiology 1986, 11–14. Dordrecht: Springer Netherlands, 1986. http://dx.doi.org/10.1007/978-94-009-4251-6_3.
Chatterjee, K. „Mechanism of Action of Inotropic Agents in Heart Failure“. In Update in Intensive Care and Emergency Medicine, 213–33. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-83453-0_15.
Koyama, Nobuhiro, und Hiroshi Tomoda. „Mechanism of Action of New Antiinfectious Agents from Microorganisms“. In Chembiomolecular Science, 293–300. Tokyo: Springer Japan, 2012. http://dx.doi.org/10.1007/978-4-431-54038-0_29.
Navarro, J., M. C. Grossetête, J. L. Touraine und J. Traeger. „The Immunosuppressive Fraction Isolated from Uremic Ultrafiltrates: Attempted Characterization of the Mechanism of Action“. In Advances in Experimental Medicine and Biology, 157–60. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4684-5445-1_25.
Kopia, G. A., und R. R. Ruffolo. „Mechanism of Action of Adrenergic Agents in Acute Congestive Heart Failure“. In Update in Intensive Care and Emergency Medicine, 244–65. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-83453-0_17.
Rees, K. R. „Mechanism of Action of Certain Exogenous Toxic Agents in Liver Cells“. In Novartis Foundation Symposia, 53–73. Chichester, UK: John Wiley & Sons, Ltd., 2008. http://dx.doi.org/10.1002/9780470719336.ch3.
Alousi, Adawia A. „Classification and Mechanism of Action of the Cardiac Inotropic Agents: An Overview“. In Developments in Cardiovascular Medicine, 331–40. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-2057-9_26.
Konferenzberichte zum Thema "Immunosuppressive agents Mechanism of action":
Ben-Hur, Ehud. „Phthalocyanines as photosensitizing agents for tumors--mechanism of action“. In Europto Biomedical Optics '93, herausgegeben von Giulio Jori, Johan Moan und Willem M. Star. SPIE, 1994. http://dx.doi.org/10.1117/12.168667.
Delgado-Mata, Carlos, und Jesus Ibanez-Martinez. „An Emotion Affected Action Selection Mechanism for Multiple Virtual Agents“. In 16th International Conference on Artificial Reality and Telexistence--Workshops (ICAT'06). IEEE, 2006. http://dx.doi.org/10.1109/icat.2006.37.
Zihlif, Malek A., Laurence P. G. Wakelin, Daniel Catchpoole und Bernard Stewart. „Abstract 744: Determining the mechanism of action of novel bisintercalating agents using the cDNA microarray technology“. In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-744.
Hysi, Eno, Muhannad N. Fadhel, Anoja Giles, Yanjie Wang, Joseph A. Sebastian, Gregory J. Czarnota, Agata A. Exner und Michael C. Kolios. „Fundamental studies comparing nanobubbles and microbubbles as vascular disrupting agents: Elucidating on the mechanism of action using photoacoustic imaging (Conference Presentation)“. In Photons Plus Ultrasound: Imaging and Sensing 2020, herausgegeben von Alexander A. Oraevsky und Lihong V. Wang. SPIE, 2020. http://dx.doi.org/10.1117/12.2544302.
Bara, L., J. M. Walen-ga, M. Petitou, M. Samama, J. Fareed und J. Choay. „STUDIES ON THE MECHANISM OF THE ANTITHROMBOTIC ACTION OF A CHEMICALLY SYNTHESIZED HEPARIN PENTASACCHARIDE“. In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644182.
Ardón, Paola, Èric Pairet, Katrin S. Lohan, Subramanian Ramamoorthy und Ron P. A. Petrick. „Building Affordance Relations for Robotic Agents - A Review“. In Thirtieth International Joint Conference on Artificial Intelligence {IJCAI-21}. California: International Joint Conferences on Artificial Intelligence Organization, 2021. http://dx.doi.org/10.24963/ijcai.2021/590.
Altman, Allison R., Beom Kang Huh, Abhishek Chandra, Wei-Ju Tseng, Ling Qin und X. Sherry Liu. „3D In Vivo Bone Dynamic Imaging of PTH’s Anabolic Action“. In ASME 2013 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/sbc2013-14671.
Hu, Yujing, Yingfeng Chen, Changjie Fan und Jianye Hao. „Explicitly Coordinated Policy Iteration“. In Twenty-Eighth International Joint Conference on Artificial Intelligence {IJCAI-19}. California: International Joint Conferences on Artificial Intelligence Organization, 2019. http://dx.doi.org/10.24963/ijcai.2019/51.
Nikonov, G., und I. Baskova. „PROTECTIVE ANTITHROMBOTIC ACTION OF THE PREPARATIONS FROM THE LEECHES HIRUDO MED ICINAL IS“. In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643079.
Maubert, Bastien, Sophie Pinchinat, Francois Schwarzentruber und Silvia Stranieri. „Concurrent Games in Dynamic Epistemic Logic“. In Twenty-Ninth International Joint Conference on Artificial Intelligence and Seventeenth Pacific Rim International Conference on Artificial Intelligence {IJCAI-PRICAI-20}. California: International Joint Conferences on Artificial Intelligence Organization, 2020. http://dx.doi.org/10.24963/ijcai.2020/260.